N@N

Robyn Karnauskas Reiterated (AMGN) at Strong Buy and Held Target at $320 on, Apr 12th, 2024

Robyn Karnauskas of Truist Securities, Reiterated "Amgen Inc." (AMGN) at Strong Buy and Held Target at $320 on, Apr 12th, 2024.

Robyn has made no other calls on AMGN in the last 4 months.

There are 8 other peers that have a rating on AMGN. Out of the 8 peers that are also analyzing AMGN, 3 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Gary Nachman of "Raymond James" Initiated at Hold on, Thursday, March 28th, 2024
• Terence Flynn of "Morgan Stanley" Maintained at Hold with Decreased Target to $278 on, Wednesday, February 7th, 2024
• Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $314 on, Monday, January 29th, 2024

These are the ratings of the 5 analyists that currently disagree with Robyn

---

• Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $329 on, Wednesday, April 3rd, 2024
• Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $350 on, Thursday, February 8th, 2024
• Jay Olson of "Oppenheimer" Reiterated at Buy and Held Target at $350 on, Thursday, February 1st, 2024
• Narumi Nakagiri of "Daiwa Capital" Upgraded from Hold to Strong Buy and Held Target at $320 on, Thursday, December 21st, 2023
• Evan David Seigerman of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $326 on, Tuesday, December 19th, 2023

Contributing Sources

---